{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:14:36Z","timestamp":1792620876858,"version":"4.5.0"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,8,15]]},"abstract":"Importance<\/jats:title>Surgical repairs of apical\/uterovaginal prolapse are commonly performed using native tissue pelvic ligaments as the point of attachment for the vaginal cuff after a hysterectomy. Clinicians may recommend vaginal estrogen in an effort to reduce prolapse recurrence, but the effects of intravaginal estrogen on surgical prolapse management are uncertain.<\/jats:p><\/jats:sec>Objective<\/jats:title>To compare the efficacy of perioperative vaginal estrogen vs placebo cream on prolapse recurrence following native tissue surgical prolapse repair.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This randomized superiority clinical trial was conducted at 3 tertiary US clinical sites (Texas, Alabama, Rhode Island). Postmenopausal women (N\u2009=\u2009206) with bothersome anterior and apical vaginal prolapse interested in surgical repair were enrolled in urogynecology clinics between December 2016 and February 2020.<\/jats:p><\/jats:sec>Interventions<\/jats:title>The intervention was 1 g of conjugated estrogen cream (0.625 mg\/g) or placebo, inserted vaginally nightly for 2 weeks and then twice weekly to complete at least 5 weeks of application preoperatively; this continued twice weekly for 12 months postoperatively. Participants underwent a vaginal hysterectomy (if uterus present) and standardized apical fixation (either uterosacral or sacrospinous ligament fixation).<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was time to failure of prolapse repair by 12 months after surgery defined by at least 1 of the following 3 outcomes: anatomical\/objective prolapse of the anterior or posterior walls beyond the hymen or the apex descending more than one-third of the vaginal length, subjective vaginal bulge symptoms, or repeated prolapse treatment. Secondary outcomes included measures of urinary and sexual function, symptoms and signs of urogenital atrophy, and adverse events.<\/jats:p><\/jats:sec>Results<\/jats:title>Of 206 postmenopausal women, 199 were randomized and 186 underwent surgery. The mean (SD) age of participants was 65\u2009(6.7) years. The primary outcome was not significantly different for women receiving vaginal estrogen vs placebo through 12 months: 12-month failure incidence of 19% (n\u2009=\u200920) for vaginal estrogen vs 9% (n\u2009=\u200910) for placebo (adjusted hazard ratio, 1.97 [95% CI, 0.92-4.22]), with the anatomic recurrence component being most common, rather than vaginal bulge symptoms or prolapse repeated treatment. Masked surgeon assessment of vaginal tissue quality and estrogenization was significantly better in the vaginal estrogen group at the time of the operation. In the subset of participants with at least moderately bothersome vaginal atrophy symptoms at baseline (n\u2009=\u2009109), the vaginal atrophy score for most bothersome symptom was significantly better at 12 months with vaginal estrogen.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>Adjunctive perioperative vaginal estrogen application did not improve surgical success rates after native tissue transvaginal prolapse repair.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT02431897<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jama.2023.12317","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:29:56Z","timestamp":1692113396000},"page":"615","source":"Crossref","is-referenced-by-count":27,"title":["Perioperative Vaginal Estrogen as Adjunct to Native Tissue Vaginal Apical Prolapse Repair"],"prefix":"10.1001","volume":"330","author":[{"given":"David D.","family":"Rahn","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly E.","family":"Richter","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian W.","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Women & Infants Hospital of Rhode Island, Providence"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E.","family":"Pruszynski","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda S.","family":"Hynan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Peter O\u2019Donnell Jr School of Public Health, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"joi230080r1","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/AOG.0000000000000286","article-title":"Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery.","volume":"123","author":"Wu","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"5","key":"joi230080r2","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1097\/AOG.0b013e3181f73729","article-title":"Lifetime risk of undergoing surgery for pelvic organ prolapse.","volume":"116","author":"Smith","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"10","key":"joi230080r3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012376","article-title":"Surgery for women with apical vaginal prolapse.","volume":"10","author":"Maher","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"19","key":"joi230080r4","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1001\/jama.2013.4919","article-title":"Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse.","volume":"309","author":"Nygaard","year":"2013","journal-title":"JAMA"},{"issue":"6","key":"joi230080r5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/AOG.0000000000002051","article-title":"Cumulative incidence of a subsequent surgery after stress urinary incontinence and pelvic organ prolapse procedure.","volume":"129","author":"Wu","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"3","key":"joi230080r6","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ajog.2003.08.040","article-title":"Impact of menopause on collagen subtypes in the arcus tendineous fasciae pelvis.","volume":"190","author":"Moalli","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"joi230080r7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1067\/mob.2002.124845","article-title":"Regulation of matrix metalloproteinase expression by estrogen in fibroblasts that are derived from the pelvic floor.","volume":"187","author":"Moalli","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"joi230080r9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00192-014-2554-z","article-title":"Vaginal estrogen use in postmenopausal women with pelvic floor disorders: systematic review and practice guidelines.","volume":"26","author":"Rahn","year":"2015","journal-title":"Int Urogynecol J"},{"issue":"9","key":"joi230080r10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007063.pub2","article-title":"Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women.","author":"Ismail","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"joi230080r11","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1097\/SPV.0000000000000899","article-title":"Design of a randomized clinical trial of perioperative vaginal estrogen versus placebo with transvaginal native tissue apical prolapse repair (Investigation to Minimize Prolapse Recurrence of the Vagina using Estrogen: IMPROVE).","volume":"27","author":"Rahn","year":"2021","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"14","key":"joi230080r12","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1001\/jama.2021.3305","article-title":"Treatment of women after bilateral salpingo-oophorectomy performed prior to natural menopause.","volume":"326","author":"Kaunitz","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"joi230080r13","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1097\/AOG.0b013e3181bf9cc8","article-title":"Racial differences in pelvic organ prolapse.","volume":"114","author":"Whitcomb","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"2","key":"joi230080r14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.cct.2008.12.001","article-title":"Operations and pelvic muscle training in the management of apical support loss (OPTIMAL) trial: design and methods.","volume":"30","author":"Barber","year":"2009","journal-title":"Contemp Clin Trials"},{"issue":"10","key":"joi230080r15","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1001\/jama.2014.1719","article-title":"Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial.","volume":"311","author":"Barber","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"joi230080r16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ajog.2004.12.025","article-title":"Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7).","volume":"193","author":"Barber","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"joi230080r17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0002-9378(96)70243-0","article-title":"The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.","volume":"175","author":"Bump","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"joi230080r18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1067\/mob.2003.379","article-title":"Validation of two global impression questionnaires for incontinence.","volume":"189","author":"Yalcin","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"joi230080r19","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00192-012-2020-8","article-title":"A new measure of sexual function in women with pelvic floor disorders (PFD): the Pelvic Organ Prolapse\/Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR).","volume":"24","author":"Rogers","year":"2013","journal-title":"Int Urogynecol J"},{"issue":"4","key":"joi230080r20","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/gme.0b013e3181a48c4e","article-title":"Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally.","volume":"16","author":"Bachmann","year":"2009","journal-title":"Menopause"},{"issue":"6","key":"joi230080r21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1191\/1740774504cn049oa","article-title":"The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA.","volume":"1","author":"Mallinckrodt","year":"2004","journal-title":"Clin Trials"},{"issue":"5-6","key":"joi230080r22","first-page":"195","article-title":"Obesity as a risk for the recurrence of anterior vaginal wall prolapse after anterior colporrhaphy.","volume":"58","author":"Kawasaki","year":"2013","journal-title":"J Reprod Med"},{"issue":"2","key":"joi230080r23","doi-asserted-by":"publisher","first-page":"252.e1","DOI":"10.1016\/j.ajog.2022.04.017","article-title":"Risk factors for pelvic organ prolapse recurrence after sacrospinous hysteropexy or vaginal hysterectomy with uterosacral ligament suspension.","volume":"227","author":"Schulten","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"joi230080r24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ijgo.2007.11.008","article-title":"Wide genital hiatus is a risk factor for recurrence following anterior vaginal repair.","volume":"101","author":"Medina","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"joi230080r25","doi-asserted-by":"publisher","first-page":"718.e1","DOI":"10.1016\/j.ajog.2015.12.027","article-title":"Genital hiatus size is associated with and predictive of apical vaginal support loss.","volume":"214","author":"Lowder","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"joi230080r26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0378-5122(92)90208-L","article-title":"Preoperative treatment with oestradiol in women scheduled for vaginal operation for genital prolapse: a randomised, double-blind trial.","volume":"15","author":"Felding","year":"1992","journal-title":"Maturitas"},{"issue":"4","key":"joi230080r27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/SPV.0b013e31825e6401","article-title":"A randomized clinical trial of the impact of local estrogen on postoperative tissue quality after vaginal reconstructive surgery.","volume":"18","author":"Karp","year":"2012","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"9","key":"joi230080r28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025141","article-title":"Randomised controlled trial to investigate the effectiveness of local oestrogen treatment in postmenopausal women undergoing pelvic organ prolapse surgery (LOTUS): a pilot study to assess feasibility of a large multicentre trial.","volume":"10","author":"Verghese","year":"2020","journal-title":"BMJ Open"},{"issue":"10","key":"joi230080r29","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1210\/jc.2014-1216","article-title":"Effects of preoperative local estrogen in postmenopausal women with prolapse: a randomized trial.","volume":"99","author":"Rahn","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"joi230080r30","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S1357-2725(98)00058-2","article-title":"The role of apoptosis in wound healing.","volume":"30","author":"Greenhalgh","year":"1998","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"joi230080r31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000339613","article-title":"Wound repair and regeneration.","volume":"49","author":"Reinke","year":"2012","journal-title":"Eur Surg Res"},{"issue":"11","key":"joi230080r32","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1001\/jama.2019.12812","article-title":"Effect of vaginal mesh hysteropexy vs vaginal hysterectomy with uterosacral ligament suspension on treatment failure in women with uterovaginal prolapse.","volume":"322","author":"Nager","year":"2019","journal-title":"JAMA"},{"issue":"7","key":"joi230080r33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/SPV.0000000000000803","article-title":"Design of a 3-arm randomized trial for posthysterectomy vault prolpase involving sacral colpopexy, transvaginal mesh, and native tissue apical repair: the apcial suspension repair for vault prolapse in a three-arm randomized trial.","volume":"26","author":"Menefee","year":"2020","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"joi230080r8","first-page":"402","volume-title":"Urogynecology and Reconstructive Pelvic Surgery","author":"Karram","year":"2022","edition":"5th ed"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2808329\/jama_rahn_2023_oi_230080_1691609286.40614.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:30:09Z","timestamp":1692113409000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2808329"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,8,15]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.12317","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,15]]}}}